Investors & Media

Ionis partners with Metagenomi to add gene editing to its broad technology platform

Collaboration with a leader in gene editing systems is Ionis’ latest move to expand and diversify its technology CRISPR-Cas gene editing is a natural extension of Ionis’ innovative approach to delivering potentially transformative therapies Ionis to hold webcast Nov. 14 at 8 a.m.

Read more
You are now leaving to visit